Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-23 5:05 pm Purchase | 2025-10-16 | 13G | RANI THERAPEUTICS HLDGS INC CO RANI | Invus Public Equities, L.P. | 9,825,911 9.990% | 9,825,911 (New Position) | Filing History |
| 2025-10-14 5:14 pm Purchase | 2025-10-06 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | Invus Public Equities, L.P. | 11,538,460 7.800% | 11,538,460 (New Position) | Filing History |
| 2025-10-02 5:04 pm Purchase | 2025-09-26 | 13G | TENAX THERAPEUTICS INC PAR TENX | Invus Public Equities, L.P. | 427,141 9.400% | 427,141 (New Position) | Filing History |
| 2025-09-22 5:22 pm Purchase | 2025-09-19 | 13G | TANGO THERAPEUTICS INC TNGX | Invus Public Equities, L.P. | 5,883,188 5.300% | 5,883,188 (New Position) | Filing History |
| 2025-09-22 3:15 pm Purchase | 2025-09-18 | 13G | REZOLUTE INC RZLT | Invus Public Equities, L.P. | 4,870,000 5.400% | 4,870,000 (New Position) | Filing History |
| 2025-09-08 5:43 pm Purchase | 2025-08-29 | 13G | VTV THERAPEUTICS INC VTVT | Invus Public Equities, L.P. | 348,083 9.990% | 348,083 (New Position) | Filing History |
| 2025-07-31 2:56 pm Purchase | 2025-06-30 | 13G | BICARA THERAPEUTICS INC BCAX | Invus Public Equities, L.P. | 5,216,969 9.600% | 2,144,142 (+69.78%) | Filing History |
| 2025-07-31 2:48 pm Purchase | 2025-06-30 | 13G | INVENTIVA SA ADR IVA | Invus Public Equities, L.P. | 14,814,813 10.600% | 7,407,407 (+100.00%) | Filing History |
| 2025-07-29 1:21 pm Sale | 2025-06-30 | 13G | KALARIS THERAPEUTICS INC KLRS | Invus Public Equities, L.P. | 282,586 1.500% | -4,247 (-1.48%) | Filing History |
| 2025-04-17 6:50 pm Purchase | 2025-03-31 | 13G | SOLID BIOSCIENCES INC SLDB | Invus Public Equities, L.P. | 7,415,905 9.600% | 3,666,864 (+97.81%) | Filing History |
| 2025-04-17 4:30 pm Purchase | 2023-12-31 | 13G | NANOBIOTIX S A SPONSORED ADS NBTX | Invus Public Equities, L.P. | 4,232,829 8.900% | 4,232,829 (New Position) | Filing History |
| 2025-04-11 4:43 pm Purchase | 2022-09-02 | 13G | ABIVAX SA SPONSORED ADS ABVX | Invus Public Equities, L.P. | 5,403,985 8.500% | 5,403,985 (New Position) | Filing History |
| 2025-03-31 5:04 pm Purchase | 2024-10-17 | 13G | INVENTIVA SA ADR IVA | Invus Public Equities, L.P. | 7,407,406 7.800% | 7,407,406 (New Position) | Filing History |
| 2025-02-12 4:30 pm Purchase | 2024-12-31 | 13G | SOLID BIOSCIENCES INC SLDB | Invus Public Equities, L.P. | 3,749,041 9.400% | 1,000,000 (+36.38%) | Filing History |
| 2025-02-12 4:30 pm Unchanged | 2024-12-31 | 13G | VIGIL NEUROSCIENCE INC VIGL | Invus Public Equities, L.P. | 1,991,038 4.900% | 0 (Unchanged) | Filing History |
| 2025-02-12 4:30 pm Sale | 2024-12-31 | 13G | SYROS PHARMACEUTICALS INC SYRS | Invus Public Equities, L.P. | 1,063,829 3.800% | -2,587,372 (-70.86%) | Filing History |
| 2025-02-12 4:30 pm Sale | 2024-12-31 | 13G | GOSSAMER BIO INC GOSS | Invus Public Equities, L.P. | 6,258,880 2.800% | -8,072,642 (-56.33%) | Filing History |
| 2025-02-12 4:30 pm Sale | 2024-12-31 | 13G | SCHOLAR ROCK HLDG CORP SRRK | Invus Public Equities, L.P. | 10,825,013 11.400% | -2,009,433 (-15.66%) | Filing History |
| 2024-11-12 4:58 pm Purchase | 2024-09-30 | 13G | SOLID BIOSCIENCES INC SLDB | Invus Public Equities, L.P. | 2,749,041 7.100% | 240,898 (+9.60%) | Filing History |
| 2024-11-12 4:40 pm Sale | 2024-09-30 | 13G | GOSSAMER BIO INC GOSS | Invus Public Equities, L.P. | 14,331,522 6.300% | -27,358 (-0.19%) | Filing History |